Hemangioendothelioma — Trials

Hemangioendothelioma — Trials · CancerIndex

Clinical trials

Registered studies

21 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05228015	Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors	terminated	Phase 1	67	Ikena OncologyINDUSTRY	3	Nov 18, 2024	clinicaltrials
NCT02110069	A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors	terminated	Phase 2	4	Boston Children's HospitalOTHER	1	Sep 21, 2023	clinicaltrials

Data updated 22 days agoSource updated Nov 18, 2024source: clinicaltrials